Peer-reviewedCC BY-NC-ND 4.0BMC Public Health
COVID-19 and subsequent new allergy drug prescriptions: a matched cohort study in Japan
Related
- Maternal opioid prescriptions and subsequent risk of hospital admission in offspring in South Korea: A nationwide birth cohort study
- COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study
- Takayasu Arteritis in a Middle-aged Woman Following Prolonged Subsequent Fever after COVID-19 Infection: An Early Diagnosis Using Contrast-enhanced CT
- Commentary: Cat exposure and asthma outcomes in a cohort of children with asthma and allergy
- Prospective birth cohort: Cephalosporins drive gut microbiota and food allergy☆
BibTeX
@article{miyamori2026covid19,
title = {{COVID-19 and subsequent new allergy drug prescriptions: a matched cohort study in Japan}},
author = {Daisuke Miyamori and Shuhei Yoshida and Masanori Ito},
journal = {BMC Public Health},
year = {2026},
month = oct,
doi = {10.1186/s12889-026-29757-0},
url = {https://link.springer.com/article/10.1186/s12889-026-29757-0},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - COVID-19 and subsequent new allergy drug prescriptions: a matched cohort study in Japan
AU - Daisuke Miyamori
AU - Shuhei Yoshida
AU - Masanori Ito
PY - 2026
DA - 2026/10/14
JO - BMC Public Health
DO - 10.1186/s12889-026-29757-0
UR - https://link.springer.com/article/10.1186/s12889-026-29757-0
SN - 1471-2458
ER -